SLC2A4 and cancer: Our findings confirm hypothesis, that pointed above compensative mechanism is significantly impaired in case with coexisting cancer, because in diabetic patients with colon cancer we observed NK cells activity about fourfold lower when compared with diabetic patients without colon cancer [25] and followed by low GLUT4 expression that we demonstrated in this study.